全文获取类型
收费全文 | 14925篇 |
免费 | 1006篇 |
国内免费 | 225篇 |
专业分类
耳鼻咽喉 | 221篇 |
儿科学 | 121篇 |
妇产科学 | 154篇 |
基础医学 | 2470篇 |
口腔科学 | 275篇 |
临床医学 | 1412篇 |
内科学 | 2813篇 |
皮肤病学 | 490篇 |
神经病学 | 1077篇 |
特种医学 | 1269篇 |
外科学 | 1778篇 |
综合类 | 48篇 |
一般理论 | 3篇 |
预防医学 | 493篇 |
眼科学 | 236篇 |
药学 | 1839篇 |
中国医学 | 269篇 |
肿瘤学 | 1188篇 |
出版年
2024年 | 8篇 |
2023年 | 126篇 |
2022年 | 476篇 |
2021年 | 660篇 |
2020年 | 310篇 |
2019年 | 464篇 |
2018年 | 551篇 |
2017年 | 463篇 |
2016年 | 650篇 |
2015年 | 866篇 |
2014年 | 1014篇 |
2013年 | 1096篇 |
2012年 | 1472篇 |
2011年 | 1496篇 |
2010年 | 887篇 |
2009年 | 674篇 |
2008年 | 885篇 |
2007年 | 848篇 |
2006年 | 692篇 |
2005年 | 637篇 |
2004年 | 558篇 |
2003年 | 405篇 |
2002年 | 316篇 |
2001年 | 168篇 |
2000年 | 136篇 |
1999年 | 80篇 |
1998年 | 45篇 |
1997年 | 29篇 |
1996年 | 24篇 |
1995年 | 11篇 |
1994年 | 12篇 |
1993年 | 7篇 |
1992年 | 22篇 |
1991年 | 14篇 |
1990年 | 13篇 |
1989年 | 11篇 |
1988年 | 6篇 |
1987年 | 3篇 |
1986年 | 8篇 |
1985年 | 6篇 |
1983年 | 3篇 |
1977年 | 1篇 |
1976年 | 2篇 |
1974年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
Alveolar soft part sarcoma: MR and angiographic findings 总被引:5,自引:5,他引:0
Suh JS Cho J Lee SH Shin KH Yang WI Lee JH Cho JH Suh KJ Lee YJ Ryu KN 《Skeletal radiology》2000,29(12):680-689
Objective. To present the MR and angiographic findings of alveolar soft part sarcoma (ASPS).
Design and patients. MR examinations (12 tumors of 10 patients) of ASPS performed at multiple hospitals were retrospectively reviewed. The tumors
were found in the thigh (n=4), lower leg (n=4), femur (n=2, local metastasis), scalp (n=1) and arm (n=1). The MR signal characteristics including signal intensity, homogeneity and signal void of lesions and bony invasion including
direct invasion or local metastasis were evaluated. Angiographic findings (n=4) and post-embolotherapy follow-up MR imaging (n=2) findings were also assessed.
Results. Local bony metastasis was found in two cases. Seven tumors showed heterogeneous high signal intensity on T1- and T2-weighted
images with good enhancement. One tumor had a very high signal on T1-weighted images. Eight tumors (67%) showed numerous signal
voids in or near the tumors. All four angiographic studies showed numerous enlarged vessels, arteriovenous shunts and delayed
washout. Two cases mimicked arteriovenous malformations on angiographic studies but MR images demonstrated solid soft tissue
components as well as tortuous vessels.
Conclusions. High signal on T1-weighted image and numerous signal voids are highly suggestive of ASPS, although they are not universal
as has been suggested and arteriovenous malformation should be included in the differential diagnosis. Local bony metastases
in ASPS were seen in two cases and should be carefully investigated.
Received: 12 April 2000 Revision requested: 27 June 2000, 8 August 2000 Revision received: 2 August 2000, 21 August 2000 Accepted:
22 August 2000 相似文献
92.
93.
Novel oral transforming growth factor‐β signaling inhibitor EW‐7197 eradicates CML‐initiating cells 下载免费PDF全文
Kazuhito Naka Kaori Ishihara Yoshie Jomen Cheng Hua Jin Dong‐Hyun Kim Yoon‐Kang Gu Eun‐Sook Jeong Shaoguang Li Daniela S. Krause Dong‐Wook Kim Eunjin Bae Yoshihiro Takihara Atsushi Hirao Hiroko Oshima Masanobu Oshima Akira Ooshima Yhun Yhong Sheen Seong‐Jin Kim Dae‐Kee Kim 《Cancer science》2016,107(2):140-148
Recent strategies for treating CML patients have focused on investigating new combinations of tyrosine kinase inhibitors (TKIs) as well as identifying novel translational research agents that can eradicate CML leukemia‐initiating cells (CML‐LICs). However, little is known about the therapeutic benefits such CML‐LIC targeting therapies might bring to CML patients. In this study, we investigated the therapeutic potential of EW‐7197, an orally bioavailable transforming growth factor‐β signaling inhibitor which has recently been approved as an Investigational New Drug (NIH, USA), to suppress CML‐LICs in vivo. Compared to TKI treatment alone, administration of TKI plus EW‐7197 to CML‐affected mice significantly delayed disease relapse and prolonged survival. Notably, combined treatment with EW‐7197 plus TKI was effective in eliminating CML‐LICs even if they expressed the TKI‐resistant T315I mutant BCR‐ABL1 oncogene. Collectively, these results indicate that EW‐7197 may be a promising candidate for a new therapeutic that can greatly benefit CML patients by working in combination with TKIs to eradicate CML‐LICs. 相似文献
94.
Moon-Woo Seong Kyu Hyung Kim Il Yong Chung Eunyoung Kang Jong Won Lee Sue K. Park Min Hyuk Lee Jeong Eon Lee Dong-Young Noh Byung Ho Son Hai-Lin Park Sung Im Cho Sung Sup Park Sung-Won Kim 《Breast cancer research and treatment》2014,146(1):63-69
Triple-negative breast cancer (TNBC) accounts for 12–24 % of all breast cancers. Here, we studied 221 familial breast and/or ovarian cancer patients from 37 hospitals using a comprehensive approach to identify large genomic rearrangements (LGRs) as well as sequence variants, and investigated the association between BRCA1/2 mutational status and TNBC. We performed direct sequencing or mutation scanning followed by direct sequencing. Then, 143 BRCA1/2 mutation-negative patients were screened for LGRs. In this study, the prevalence of BRCA1/2 mutations was high (36.9 %). The prevalence of BRCA1 mutations was similar to that of BRCA2 mutations: 49.4 versus 50.6 %, respectively. TNBC was diagnosed in 35.2 % of BRCA1/2 mutation carriers and 57.1 % of BRCA1 mutation carriers. Conversely, two-thirds of TNBC patients carried BRCA1/2 mutation(s), and about half were BRCA1 mutation carriers. When stratified by the mutated gene, TNBC prevalence in BRCA1 mutation carriers was significantly lower when there was a family history of ovarian cancer. Our multinomial logistic regression model demonstrated that no single factor was sufficient, and at least two factors, such as a patient with family history of both breast cancer and ovarian cancer or a patient diagnosed at a relatively young age (<40 years) with a TNBC phenotype, are necessary to indicate BRCA1/2 genetic testing in this population. Our results suggest that TNBC is a strong predictor for the presence of a BRCA1 mutation in this population, but additional risk factors should also be evaluated to ascertain a 10 % or higher prior probability of BRCA1/2 mutation testing. 相似文献
95.
Inhibitory action of water soluble fraction of Terminalia chebula on systemic and local anaphylaxis 总被引:3,自引:0,他引:3
Shin TY Jeong HJ Kim DK Kim SH Lee JK Kim DK Chae BS Kim JH Kang HW Lee CM Lee KC Park ST Lee EJ Lim JP Kim HM Lee YM 《Journal of ethnopharmacology》2001,74(2):133-140
We investigated the effects of the water soluble fraction of Terminalia chebula (Combretaceae) (WFTC) on systemic and local anaphylaxis. WFTC administered 1h before compound 48/80 injection inhibited compound 48/80-induced anaphylactic shock 100% with doses of 0.01-1.0 g/kg. When WFTC was administered 5 or 10 min after compound 48/80 injection, the mortality also decreased in a dose-dependent manner. Passive cutaneous anaphylaxis was inhibited by 63.5+/-7.8% by oral administration of WFTC (1.0 g/kg). When WFTC was pretreated at concentrations ranging from 0.005 to 1.0 g/kg, the serum histamine levels were reduced in a dose-dependent manner. WFTC (0.01-1.0 mg/ml) also significantly inhibited histamine release from rat peritoneal mast cells (RPMC) by compound 48/80. However, WFTC (1.0 mg/ml) had a significant increasing effect on anti-dinitrophenyl IgE-induced tumor necrosis factor-alpha production from RPMC. These results indicate that WFTC may possess a strong antianaphylactic action. 相似文献
96.
Jun Young Park Ju Hyeon Kim Young Joo Sim Ho Joong Jeong Jae Hyun Lee Ghi Chan Kim 《Medicine》2022,101(35)
The purpose of this study was to confirm the association between the serum vitamin D levels and ischemic stroke lesion size, functional ability, and cognitive function in elderly ischemic stroke patients. This study included Korean ischemic stroke patients aged 65 to 85 years. The size of the lesion was measured in brain images taken within 24 hours of hospitalization. The level of 25-(OH) Vitamin D (ng/mL), a metabolite of vitamin D, in the serum collected within 48 hours of hospitalization, and the modified Barthel index (MBI), gait performance, the muscle power of hip and knee extensors on the hemiplegic side, and mini-mental status examination (MMSE) were recorded within 1 week of the onset of the disease. Each factor was compared through correlation analysis, and the significance was confirmed using the Spearman correlation coefficient method. The association between the serum vitamin D levels and the size of the ischemic stroke lesion, the MBI, gait performance, the muscle power of hip and knee extensors on the hemiplegic side, and the MMSE were analyzed. It was confirmed that there was a significant correlation between all the factors (P < .005). In patients with serum vitamin D levels of ≥ 30 ng/mL, both the functional ability and cognitive functions were better than in patients lower than 30 ng/mL. We confirmed the lower the level of serum vitamin D levels, the larger the size of the ischemic stroke lesion when it occurred in elderly Koreans. And we confirmed that serum vitamin D levels affected the functional ability and cognitive function. And we recommend that elderly Koreans should maintain their blood vitamin D level above 30 ng/mL. We believe that this will help preserve the functional ability and cognitive function when ischemic stroke occurred. 相似文献
97.
98.
Changjoo Ahn Changshin Kang Hong Joon Ahn Yeonho You Jung Soo Park Jin Hong Min Wonjoon Jeong Yongchul Cho Seung Ryu Yong Nam In 《Medicine》2022,101(46)
Cholesterol is an essential substance to maintain cell membranes. Low levels of total cholesterol (TC) are associated with poor prognosis in critically ill patients. Cardiac arrest-induced whole-body ischemia and reperfusion injury cause a sepsis-like syndrome. The Cholesterol level in post-cardiac arrest patients may indicate the degree of endotoxemia or inflammation caused by ischemic and reperfusion injury. We aimed to investigate the association of TC levels with neurologic outcome of out-of-hospital cardiac arrest (OHCA) survivors who underwent target temperature management (TTM). This was a retrospective single-center observational study from May 2018 to April 2021 on a cohort of 106 patients. TC levels were determined in samples obtained immediately and at 24, 48, and 72 hours after the return of spontaneous circulation (ROSC). The primary outcome was poor neurologic outcome at 3 months after ROSC. Poor neurologic outcome was defined by cerebral performance categories 3 to 5. Sixty patients had a poor neurologic outcome. TC levels were significantly lower in the poor neurologic outcome group at each time point. The TC levels for predicting poor neurologic outcome had a sensitivity of 80.8%, with 67.6% specificity at 48 hours (TC48) after ROSC. The areas under the curve value of TC48 was 0.771 (0.670–0.853), with a cutoff value of 114 mg/dL. TC level at 48 hours after ROSC was a helpful marker for the 3-month poor neurologic outcome. This might be an easily accessible predictive marker of neurologic outcome in OHCA survivors treated with TTM. 相似文献
99.
100.